Physician profile
Robert C Hamp
NPI 1760443188
$2,598.30
in general payments reported to CMS, 2019-2025
19 companies · $433 in 2025
The $433 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $551 · 2020: $56.30 · 2021: $39.58 · 2022: $547 · 2023: $562 · 2024: $410 · 2025: $433.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,404.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $669.14 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $661.99 | 2019-2025 | Precision 1, Hydrus Microstent, Precision7 |
| Sun Pharmaceutical Industries INC. | $255.10 | 2023-2025 | Cequa |
| Allergan, INC. | $137.76 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $128.21 | 2024-2025 | Xdemvy |
| Abbvie INC. | $120.08 | 2022-2025 | |
| Oyster Point Pharma, INC. | $119.91 | 2022-2024 | Tyrvaya, Ryzumvi |
| Bausch & Lomb Americas INC. | $117.32 | 2022-2024 | Xiidra, Miebo, Infuse |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $81.73 | 2019-2021 | |
| Harrow Eye, LLC | $63.39 | 2024-2025 | Vevye |
| Coopervision INC. | $47.97 | 2019-2022 | |
| Ani Pharmaceuticals, INC. | $45.45 | 2023 | Purified Cortrophin Gel |
| Notal Vision, INC. | $32.84 | 2024 | Foresee Home |
| Horizon Therapeutics Plc | $27.97 | 2023 | Tepezza |
| Dompe US, INC. | $20.23 | 2025 | Oxervate |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyevance Pharmaceuticals LLC | $19.81 | 2019 | |
| Novartis Pharmaceuticals Corporation | $17.74 | 2022 | |
| Shire North American Group INC | $16.92 | 2019 | |
| Aerie Pharmaceuticals, INC. | $14.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Hamp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.